Logo

Dante Labs: Stripe2be

Jul 08, 2021

Dante Labs has introduced Stripe2be, a whole-genome sequencing platform and business unit dedicated to serving patients with rare diseases. Stripe2be provides personalized reports, generated with the help of artificial intelligence embedded in Dante Labs' Immensa genomic interpretation software, based on the firm's proprietary whole-genome sequencing tests. The new Stripe2be website sells test kits directly to the public.

Breaking News
The Scan

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.

New Oral Nanomedicine Strategy Targets Gut-Brain Axis to Treat IBD

A new paper in Science Advances describes a platform to design polyphenol-armored oral medicines that are effective at treating inflammatory bowel disease.

Phylogenetic Data Enables New Floristic Map

Researchers in Nature Communications use angiosperm phylogenetic data to refine the floristic regions of the world.

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.